The FDA has identified an association between breast implants and the development of anaplastic large cell lymphoma (ALCL), a rare type of non-Hodgkin’s lymphoma. This rare cancer affects cells in the immune system and can be found around the breast implant. It can be found in the skin or lymph nodes, and is not a type of breast cancer.
As of 1 February 2017, the FDA says it has received a total of 359 reports of breast implants and the development of ALCL, including nine deaths.
Most of these cancer cases occurred in people who had textured surfaces on their implants, rather than smooth surfaces.
The Gabrielli Law Firm is investigating cases on behalf of women who have developed ALCL after having breast implants. We offer a free, confidential consultation to discuss your concerns as well as how we can help.